Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial
Journal of the European Academy of Dermatology and Venereology · 2026-07 · 40 (7)
DOI: 10.1111/jdv.70237 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 02.12.2025. Verfasst von Baltazar Sanabria und 3 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil.
- Department of Dermatology, FMB-UNESP, Botucatu, SP, Brazil.
ORCID-Profile: Hélio Amante Miot, Paulo Müller Ramos
Zitieren
APA
Sanabria, B., Medeiros, M. Z., Miot, H. A., & Müller Ramos, P. (2026). Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial. Journal of the European Academy of Dermatology and Venereology, 40(7). https://doi.org/10.1111/jdv.70237
Vancouver
Sanabria B, Medeiros MZ, Miot HA, Müller Ramos P. Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial. Journal of the European Academy of Dermatology and Venereology. 2026;40(7). doi:10.1111/jdv.70237
BibTeX
@article{Sanabria2026,
author = {Sanabria, Baltazar and Medeiros, Marcelo Zanolli and Miot, Hélio Amante and Müller Ramos, Paulo},
title = {Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
volume = {40},
number = {7},
doi = {10.1111/jdv.70237}
}
EUVIMED